BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen JM, Cesta CE, Furu K, Einarsdóttir K, Gissler M, Havard A, Hernandez-Diaz S, Huybrechts KF, Kieler H, Leinonen MK, Li J, Reutfors J, Schaffer A, Selmer R, Yu Y, Zoega H, Karlstad Ø. Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia. Pharmacoepidemiol Drug Saf 2020;29:913-22. [PMID: 32492755 DOI: 10.1002/pds.5035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Shouman W, Delaney JA, Kowalec K, Ng M, Ruth C, Falk J, Leong C, Alessi-Severini S, Lavu A, Peymani P, Eltonsy S. Trends of Utilization of Antiseizure Medications Among Pregnant Women in Manitoba, Canada: A 20-Year Population-Based Study. Front Pharmacol 2022;13:871136. [PMID: 35517797 DOI: 10.3389/fphar.2022.871136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kikuchi D, Obara T, Miura R, Suzuki N, Josaka R, Tokunaga M, Ouchi R, Usui K, Okada K. Trends in the prescription of anti-seizure medicines for pregnant women outpatients with epilepsy during 2016–2020 in Japan. Seizure 2022. [DOI: 10.1016/j.seizure.2022.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Houben E, Benson RJ, Steegers EAP, Herings RMC. Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands. Epilepsy Behav 2022;127:108549. [PMID: 35042161 DOI: 10.1016/j.yebeh.2021.108549] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alsfouk BA, Almarzouqi MR, Alageel S, Alsfouk AA, Alsemari A. Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2021.12.006] [Reference Citation Analysis]
5 Pearson SA, Pratt N, de Oliveira Costa J, Zoega H, Laba TL, Etherton-Beer C, Sanfilippo FM, Morgan A, Kalisch Ellett L, Bruno C, Kelty E, IJzerman M, Preen DB, Vajdic CM, Henry D. Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future. Int J Environ Res Public Health 2021;18:13345. [PMID: 34948955 DOI: 10.3390/ijerph182413345] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Thomas SV, Jeemon P, Pillai R, Jose M, Lalithakumari AM, Murali S, Sanalkumar A, Salini RA, Pavithran V. Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021;93:127-32. [PMID: 34740142 DOI: 10.1016/j.seizure.2021.10.015] [Reference Citation Analysis]
7 Junaid M, Slack-Smith L, Wong K, Bourke J, Baynam G, Calache H, Leonard H. Epidemiology of Rare Craniofacial Anomalies: Retrospective Western Australian Population Data Linkage Study. J Pediatr 2021:S0022-3476(21)00963-X. [PMID: 34626670 DOI: 10.1016/j.jpeds.2021.09.060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Clavenna A, Campi R, Putignano D, Fortino I, Bonati M. Changes in antiepileptic drug prescriptions over a decade in childbearing women in Lombardy region, Italy. Br J Clin Pharmacol 2021. [PMID: 34427945 DOI: 10.1111/bcp.15053] [Reference Citation Analysis]